Byteflies: virtual care solutions for all Byteflies is on a mission to make virtual care available to all. The Belgian company has developed a platform for […] May 24, 2023 · MEDVIA
Colorectal cancer discovery raises hope for microbiome treatment A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University. A specific protein was […] July 7, 2020 · BioVox
Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases Brussels, Belgium / Tokyo, Japan – 27 August 2020 – Newton Biocapital I (“Newton”), an investment company in life sciences, […] August 27, 2020 · Quality by Design - Business & Communications
Montis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer Leuven, Belgium, 29 September 2020 – Montis Biosciences, a discovery stage biotech company focused on novel immuno-oncology therapeutics targeting the […] September 29, 2020 · Quality by Design - Business & Communications
Get to know Lewis Cantley: winner of the 2020 Dr. Paul Janssen Award Every year, the Dr. Paul Janssen Award for Biomedical Research is granted to a scientist who embodies the eponymous man’s […] September 30, 2020 · Janssen Pharmaceutica
Vascular dysfunction meets immune suppression Tumors create complex microenvironments where they suppress the normal functioning of the immune system. Blood vessels and macrophages are an […] November 4, 2020 · BioVox
Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers Brussels, Belgium / Tokyo, Japan – 1 December 2020 – Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe […] December 1, 2020 · Quality by Design - Business & Communications
eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Quality by Design - Business & Communications
Decades-old discoveries cause paradigm shifts in modern medicine Complete paradigm shifts in medicine are rare, but there have nevertheless been several major examples in the past hundred years. […] December 16, 2020 · V-Bio Ventures
Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center – Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies – Seed investment by Swanbridge Capital and Van Herk […] February 8, 2021 · Quality by Design - Business & Communications
Newton Biocapital invests in Flemish start-up DeuterOncology Brussels, Belgium, 24 February 2021 – Newton Biocapital I (“Newton Biocapital”), a life sciences investment fund active in Europe and […] February 24, 2021 · Quality by Design - Business & Communications
Saving man’s best friend: Volition blood test allows cheap and easy cancer screenings for dogs A Belgian invention is revolutionizing cancer diagnostics for dogs by making it possible to screen for two common canine cancers […] March 10, 2021 · BioVox
Montis Biosciences appoints René Hoet as Chief Scientific Officer Leuven, Belgium, 31 March 2021 – MONTIS BIOSCIENCES, a discovery stage biotech company focused on the development of novel immuno-oncology therapeutics […] March 31, 2021 · Quality by Design - Business & Communications
Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics Leuven, Belgium, 14 June 2021 – Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics targeting the […] June 14, 2021 · Quality by Design - Business & Communications
Cancer diagnosis and therapy in one: Precirix tackles tumors with camelid antibodies A new drug that can identify tumors, trace metastases, and treat cancer – all in one? Belgian start-up Precirix is […] August 18, 2021 · V-Bio Ventures